{"disease":{"id":"allergic-reaction","name":"allergic reaction"},"drugs":{"marketed":[{"drug_id":"bnt162b6-bivalent-original-omi-ba-4-ba-5","indication_name":"COVID-19 prevention in individuals 5 years of age and older with a history of severe allergic reaction (e.g., anaphylaxis) to a previous dose of any COVID-19 vaccine","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"BNT162b6 Bivalent (Original/OMI BA.4/BA.5)","generic_name":"bnt162b6-bivalent-original-omi-ba-4-ba-5","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2 spike protein","drug_class":"vaccine","quality_score":47,"revenue":null,"mechanism":""},{"drug_id":"bnt162b6-bivalent-original-omi-ba-4-ba-5","indication_name":"COVID-19 prevention in individuals 12 years of age and older with a history of severe allergic reaction (e.g., anaphylaxis) to a previous dose of any COVID-19 vaccine","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"BNT162b6 Bivalent (Original/OMI BA.4/BA.5)","generic_name":"bnt162b6-bivalent-original-omi-ba-4-ba-5","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2 spike protein","drug_class":"vaccine","quality_score":47,"revenue":null,"mechanism":""},{"drug_id":"bnt162b6-bivalent-original-omi-ba-4-ba-5","indication_name":"COVID-19 prevention in individuals 6 months through 4 years of age with a history of severe allergic reaction (e.g., anaphylaxis) to a previous dose of any COVID-19 vaccine","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"BNT162b6 Bivalent (Original/OMI BA.4/BA.5)","generic_name":"bnt162b6-bivalent-original-omi-ba-4-ba-5","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2 spike protein","drug_class":"vaccine","quality_score":47,"revenue":null,"mechanism":""},{"drug_id":"epinephrine","indication_name":"Allergic Reactions","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Epipen","generic_name":"epinephrine","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Alpha-1D adrenergic receptor","drug_class":"alpha-Adrenergic Agonist [EPC]","quality_score":80,"revenue":null,"mechanism":"Epipen works by stimulating the alpha-1D adrenergic receptor to rapidly increase heart rate, blood pressure, and bronchodilation."},{"drug_id":"lidocaine-hydrochloride-and-epinephrine","indication_name":"Allergic Reactions","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bupivacaine Hydrochloride And Epinephrine","generic_name":"Epinephrine","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Alpha-1D adrenergic receptor","drug_class":"alpha-Adrenergic Agonist [EPC]","quality_score":80,"revenue":null,"mechanism":"Epinephrine works by stimulating the alpha-1D adrenergic receptor to increase heart rate and blood pressure, and to constrict blood vessels."},{"drug_id":"epinephrin","indication_name":"Allergic Reactions","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Epinephrin","company_name":"United States Naval Medical Center, San Diego","drug_phase":"marketed","molecular_target":"Alpha-1A adrenergic receptor, Alpha-1B adrenergic receptor, Alpha-1D adrenergic receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":6,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05185479","title":"Analysis of Adverse Events in Anesthesia Using Artificial Intelligence","phase":"","overall_status":"COMPLETED","enrollment_count":9559,"lead_sponsor_name":"University Hospital, Strasbourg, France","has_results":false},{"nct_id":"NCT04688736","title":"Efficacy of Placebo Versus Chlorpheniramine for the Prevention of Allergic Transfusion Reactions.","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":6642,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false},{"nct_id":"NCT04761822","title":"COVID19 SARS Vaccinations: Systemic Allergic Reactions to SARS-CoV-2 Vaccinations","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":746,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT03369509","title":"Allergic Versus Non Allergic Hypersensitivity Drug Reaction (BdDAllergo)","phase":"","overall_status":"TERMINATED","enrollment_count":456,"lead_sponsor_name":"University Hospital, Grenoble","has_results":false},{"nct_id":"NCT06011629","title":"Aquacel Hypersensitivity Dressing in TJAs","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":396,"lead_sponsor_name":"Rush University Medical Center","has_results":false},{"nct_id":"NCT05670756","title":"Preoperative Survey to Evaluate Patient Allergy","phase":"","overall_status":"COMPLETED","enrollment_count":250,"lead_sponsor_name":"Nationwide Children's Hospital","has_results":true},{"nct_id":"NCT06011603","title":"Prineo Sensitivity Dressing Study","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":236,"lead_sponsor_name":"Rush University Medical Center","has_results":false},{"nct_id":"NCT03942692","title":"What is the Allergy Follow-up for Children After Anaphylactic Reaction? AFCAR : Allergy Follow-up for Children After Anaphylactic Reaction","phase":"","overall_status":"COMPLETED","enrollment_count":118,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT03525496","title":"Interest of Challenge Tests for Diagnosis of Immediate Hypersensitivity Against Iodinated Contrast Agents","phase":"","overall_status":"COMPLETED","enrollment_count":85,"lead_sponsor_name":"Centre Hospitalier Régional Metz-Thionville","has_results":false},{"nct_id":"NCT05605795","title":"Investigation of Cross-allergies Between Cefazolin and Amoxicillin With Skin Tests and Provocation Test","phase":"","overall_status":"UNKNOWN","enrollment_count":84,"lead_sponsor_name":"Fondation Hôpital Saint-Joseph","has_results":false},{"nct_id":"NCT03157505","title":"Efficacy and Safety of Birch Pollen Immunotherapy in Local Allergic Rhinitis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":78,"lead_sponsor_name":"Medical University of Silesia","has_results":false},{"nct_id":"NCT05284253","title":"Is There an Allergy to Pure Metallic Gold Microparticles?","phase":"NA","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Northern Orthopaedic Division, Denmark","has_results":false},{"nct_id":"NCT06065137","title":"Standardised Drug Provocation Testing in Perioperative Hypersensitivity","phase":"NA","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"University Hospital, Antwerp","has_results":false},{"nct_id":"NCT05185362","title":"Epidemiology of Pecan Nut Allergy","phase":"","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT00894634","title":"Study Evaluating Brompheniramine Maleate Liquid in Children and Adolescents","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":37,"lead_sponsor_name":"Wyeth is now a wholly owned subsidiary of Pfizer","has_results":false},{"nct_id":"NCT00837837","title":"Study Evaluating Chlorpheniramine Maleate Liquid in Children and Adolescents","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Wyeth is now a wholly owned subsidiary of Pfizer","has_results":false},{"nct_id":"NCT06527937","title":"Pharmacokinetics Study of DESF in Adults With Oral Allergy Syndrome","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Aquestive Therapeutics","has_results":false},{"nct_id":"NCT06957496","title":"Phleum Pratense and Dactylis Glomerata Allergen Extracts Standardization","phase":"NA","overall_status":"COMPLETED","enrollment_count":31,"lead_sponsor_name":"Inmunotek S.L.","has_results":false},{"nct_id":"NCT05533385","title":"Juniperus Oxycedrus and Cupressus Arizonica Allergen Extracts Standardisation.","phase":"NA","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Inmunotek S.L.","has_results":false},{"nct_id":"NCT05367531","title":"Assessment of Injectable Medication Platforms","phase":"NA","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Canadian Forces Health Services Centre Ottawa","has_results":false},{"nct_id":"NCT05532566","title":"Quercus Ilex and Quercus Robur Allergen Extracts Standardisation","phase":"NA","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Inmunotek S.L.","has_results":false},{"nct_id":"NCT07154004","title":"The Sponsor Assigns Test Products to Six Skin Areas According to a Concealed Randomization Schedule; Neither the Evaluating Physicians Nor the Participants Know Which Product is Applied to Which Site, Preventing Bias.","phase":"NA","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"BEIJING YUANBEN INFORMATION CONSULTING CO., LTD","has_results":false},{"nct_id":"NCT04116580","title":"Efficacy of Oral Tolerance Induction to Raw Apple","phase":"","overall_status":"COMPLETED","enrollment_count":28,"lead_sponsor_name":"Michel Bouvier","has_results":false},{"nct_id":"NCT06271993","title":"SPT for Sensitization of Collagen Dressing","phase":"NA","overall_status":"COMPLETED","enrollment_count":27,"lead_sponsor_name":"Covalon Technologies Inc.","has_results":true},{"nct_id":"NCT04510376","title":"Allergy Potential of Omeza Collagen Matrix in Human Subjects Using the Skin Prick Method","phase":"NA","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"Omeza, LLC","has_results":false},{"nct_id":"NCT07391917","title":"Human Seminal Plasma Allergy: Quality of Life","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":20,"lead_sponsor_name":"University Hospital, Angers","has_results":false},{"nct_id":"NCT04977479","title":"The Safety of Administering a Second Dose of a COVID-19 mRNA Vaccine in Individuals Who Experienced a Systemic Allergic Reaction to an Initial Dose","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT04327752","title":"Skin Adverse Reactions Occuring in Children Treated by Biotherapy for Chronic Inflammatory Disease","phase":"","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Centre Hospitalier Universitaire, Amiens","has_results":false},{"nct_id":"NCT03489694","title":"Repeatability and Reproducibility of Skin Test Endpoint Titration","phase":"","overall_status":"COMPLETED","enrollment_count":17,"lead_sponsor_name":"University of Saskatchewan","has_results":false},{"nct_id":"NCT06963411","title":"Phase 1 Crossover Study Evaluating the Safety, Tolerability, and Pharmacokinetics of KP001 in Healthy Adult Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"Kokua Pharma Inc.","has_results":false},{"nct_id":"NCT04058743","title":"Nickel Sensitivity","phase":"NA","overall_status":"TERMINATED","enrollment_count":8,"lead_sponsor_name":"Rush University Medical Center","has_results":false}],"total":31},"guidelines":[],"source":"Drug Landscape verified database"}